Position in NNVC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,820
-$440 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NNVC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CURIO WEALTH, LLC holds $34,400 across 29 Biotechnology names. NNVC ranks #8 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
279 | $9,078 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10 | $3,308 | |
| 3 | GERN |
Geron Corp
|
2,000 | $2,980 | |
| 4 | MAIA |
MAIA Biotechnology, Inc.
|
2,000 | $2,800 | |
| 5 | LTRN |
Lantern Pharma Inc.
|
2,000 | $2,740 | |
| 6 | MRNA |
Moderna, Inc.
|
46 | $2,336 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5 | $2,232 | |
| 8 | NNVC |
Nanoviricides, Inc.
This page
|
2,000 | $1,820 |
All Filings in NNVC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,820 | 2,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,260 | 2,000 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||